S.141 - End Taxpayer Subsidies for Drug Ads Act117th Congress (2021-2022) |
|Sponsor:||Sen. Shaheen, Jeanne [D-NH] (Introduced 01/28/2021)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 01/28/2021 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.141 — 117th Congress (2021-2022)All Information (Except Text)
Introduced in Senate (01/28/2021)
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.
Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.